Biomaterial-associated
infection is difficult to detect and brings
consequences that can lead to morbidity and mortality. Bacteria can
adhere to the implant surface, grow, and form biofilms. Antimicrobial
peptides (AMPs) can target and kill bacterial cells using a plethora
of mechanisms of action such as rupturing the cell membrane by creating
pores via depolarization with their cationic and amphipathic nature.
AMPs can thus be coated onto metal implants to prevent microbial cell
adhesion and growth. The aim of this systematic review was to determine
the potential clinical applications of AMP-modified implants through
in vivo induced infection models. Following a database search recently
up to 22 January 2022 using PubMed, Web of Science and Cochrane databases,
and abstract/title screening using the PRISMA framework, 24 studies
remained, of which 18 were used in the random effects meta-analysis
of standardized mean differences (SMD) to get effect sizes. Quality
of studies was assessed using SYRCLE’s risk of bias tool. The
data from these 18 studies showed that AMPs carry antibacterial effects,
and the meta-analysis confirmed the favorited antibacterial efficacy
of AMP-coated groups over controls (SMD −1.74, 95%CI [−2.26,
−1.26],
p
< 0.00001). Subgroup analysis
showed that the differences in effect size are random, and high heterogeneity
values suggested the same. HHC36 and vancomycin were the most common
AMPs for surface modification and
Staphylococcus aureus
, the most tested bacterium in vivo. Covalent binding with polymer
brush coating and physical layer-by-layer incorporation of AMPs were
recognized as key methods of incorporation to achieve desired densities.
The use of fusion peptides seemed admirable to incorporate additional
benefits such as osteointegration and wound healing and possibly targeting
more microbe strains. Further investigation into the incorporation
methods, AMP activity against different bacterial strains, and the
number of AMPs used for metal implant surface modification is needed
to progress toward potential clinical application.